Biosimilar Development Editorial Board

Source: Biosimilar Development

Hillel Cohen, Executive Director, Scientific Affairs,
Sandoz

Timothy deGavre,
U.K. Country Head,
Sandoz

Edric Engert, Managing Director, Abraxeolus Consulting

Francois-Xavier Frapaise, M.D., ClinExcel

HoUng Kim,
Head of Strategy and Operations, Celltrion

Dr. HyukChan Kwon,
Head of Medical Affairs,
Celltrion

Brian Lehman, MBA, MHA, RPh., Strategic Consultant,
Humana Pharmacy Professional Affairs

Pankaj Mohan,
CEO,
Oncobiologics

Valerie Mulligan,
VP, Global Regulatory CMC and Growth Markets, Branded Regulatory Affairs, Teva

Sue Naeyaert,
Global Head Pricing, Market Access, Government Affairs and Policy, Biosimilars, Fresenius-Kabi SwissBioSim

Don Stewart,
CEO,
PlantForm